dc.contributor.author |
Ker, James A.
|
|
dc.contributor.author |
Van Wyk, C.J.
|
|
dc.date.accessioned |
2008-03-15T07:24:15Z |
|
dc.date.available |
2008-03-15T07:24:15Z |
|
dc.date.issued |
2007-11 |
|
dc.description.abstract |
Considerable controversy exists regarding the cardiovascular safety of COX-2 inhibitors, both in patients with and without established cardiovascular disease. Currently, the major focus is on thrombotic complications presenting as myocardial infarction. In this report, we present a case of takotsubo cardiomyopathy, also known as the apical ballooning syndrome, precipitated by the use of lumiracoxib. We are concerned that this might be the first case of COX-2 inhibitor-induced apical ballooning syndrome and that more may follow. |
en |
dc.format.extent |
244840 bytes |
|
dc.format.mimetype |
application/pdf |
|
dc.identifier.citation |
Ker, J & Van Wyk, CJ 2007, 'A case of takotsubo cardiomyopathy precipitated by lumiracoxib, a selective COX-2 inhibitor', Cardiovascular Journal of Africa, vol. 18, no. 6, pp. 383-384. [http://www.cvjsa.co.za] |
en |
dc.identifier.issn |
1015-9657 |
|
dc.identifier.uri |
http://hdl.handle.net/2263/4733 |
|
dc.language.iso |
en |
en |
dc.publisher |
Clinics Cardiv |
en |
dc.rights |
Clinics Cardiv |
en |
dc.subject |
Cardiovascular disease |
en |
dc.subject |
COX-2 |
en |
dc.subject |
Takotsubo cardiomyopathy |
en |
dc.subject |
Apical ballooning syndrome |
en |
dc.subject.lcsh |
Cardiovascular system -- Diseases |
|
dc.subject.lcsh |
Cyclooxygenase 2 -- Inhibitors |
|
dc.subject.mesh |
Takotsubo Cardiomyopathy |
|
dc.title |
A case of takotsubo cardiomyopathy precipitated by lumiracoxib, a selective COX-2 inhibitor |
en |
dc.type |
Article |
en |